Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

JMP Statistical Discovery

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Pharma Relations AB

Merck Life Science A/S

New large lab building in Lund inaugurated – here are the companies moving in

Medicon Village has received a new laboratory building. On Friday last week the building was inaugurated with a ribbon-cutting ceremony by Minister for Employme...

Galenica AB

This is the future location of the new national innovation cluster

Mölndal and Goco Health Innovation City will be the site of a new national innovation cluster for advanced therapies. The business community and the Swedish gov...

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

Science to Market - S2M

SGS Fimko Ltd.

A new life science cluster formed – “We are very strong in talent”

Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the dec...

Mercodia AB

QPS Netherlands B.V

He takes over the chairmanship of Karolinska Development

Ben Toogood is appointed as the new chairman of Karolinska Developments.

About Microscope Ergonomics

Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...

The US is leaving the WHO

The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Wusson Accelerator AB

LINK Medical Research

RegSmart Life Science AB

TECHNIA AB

NorthX Biologics Matfors AB

Nytt miljardförvärv stärker Astra Zeneca inom radiofarmaka

Astra Zeneca satsar inom radioaktiva läkemedel genom att köpa Fusion Pharmaceuticals för upp till 2,4 miljarder dollar, motsvarande drygt 25 miljarder kronor.